Hypertension research - key publications using PLN antibodies

Please rate these pages to support our infographic project:
Get free premium widgets for your blog and website.

  1. Angelone, T. et al. 2008. The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism. Endocrinology. 149(10), pp.4780-4793.
  2. Boknik, P. et al. 2001. Enhanced protein phosphorylation in hypertensive hypertrophy. Cardiovascular Research. 51(4), pp.717-728.
  3. MacDonnell, S.M. et al. 2007. Calcineurin inhibition normalizes beta-adrenergic responsiveness in the spontaneously hypertensive rat. American Journal of Physiology-Heart and Circulatory Physiology. 293(5), pp.H3122-H3129.

Back to main infographic.

About us
meet the team
Badrilla is a manufacturer of outstanding antibodies against cardiac proteins and phospho-proteins, and the manufacturer of leading kits for the study of protein S-palmitoylation.

Follow us on social

Contact us
We look forward to providing your favourite antibodies and kits
gender and body